跳至主要内容
临床试验/ISRCTN97280223
ISRCTN97280223已完成未知

Application of adenosine-5-triphosphate infusions in palliative home care

niversity Maastricht (The Netherlands)0 个研究点目标入组 100 人开始时间: 2006年11月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Cancer patients for whom no systemic treatment is available, or medical treatment options are restricted to palliative/supportive care
  • 2. Life expectancy of less than six months
  • 3. The diagnosis cancer must have been confirmed histologically or cytologically
  • 4. World Health Organisation (WHO) performance status classification in cancer one or two
  • 5. Presence of at least one of the following complaints:
  • b. weight loss over 5% over last six months
  • c. anorexia

排除标准

  • 1. Symptomatic angina pectoris
  • 2. Symptomatic heart failure
  • 3. Any form of AtrioVentricular (AV)-block (assessed by Electrocardiogram [ECG])
  • 4. Cognitive dysfunction or other disease obstructing an adequate follow up
  • 5. Life expectancy of less than four weeks
  • 6. Concurrent palliative chemotherapy

研究者

发起方
niversity Maastricht (The Netherlands)

相似试验